In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

Type 1 Diabetes Efficacy Studies

$0.49 - $7.00

Select Options

Comprehensive Immunodeficient Suite

$1.52 - $6.00

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

$0.84 - $9.00

Select Options

Advantages of Evaluating Immunomodulatory Therapeutics In Vivo in Hu-PBMC NSG Mice to Investigate GVHD

$0.33 - $3.00

Select Options

HuPK A Humanized Platform for therapeutic antibody PK evaluation Field Guide

$1.73 - $10.00

Select Options

CD34+ Hu-NSG-SGM3-IL15 Tech Sheet

$0.49 - $7.00

Select Options

Studying CRS In A Diverse Population FAQS

$0.33 - $3.00

Select Options

ActionSeq 2.0

$0.38 - $3.00

Select Options